ECM-associated HSPGs, such as perlecan, bind and present pro-survival and pro-angiogenic growth factors, including FGF and VEGF, thereby reinforcing signaling pathways that promote tumor persistence under chemotherapeutic stress [50,51]. The gene discussed is HSPG2; the disease is neoplasm.